account_num,net_change,tag,tag_depth,cik
3661,-966000.0,CommonStockValue,3,921299_FIBROGEN INC
3917,-538544000.0,LiabilitiesAndStockholdersEquity,2,921299_FIBROGEN INC
3260,-28885000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,921299_FIBROGEN INC
3316,-48852000.0,StockholdersEquity,1,921299_FIBROGEN INC
3834,-1634393000.0,RetainedEarningsAccumulatedDeficit,1,921299_FIBROGEN INC
3750,-1589145000.0,AdditionalPaidInCapital,1,921299_FIBROGEN INC
3465,-567429000.0,Liabilities,1,921299_FIBROGEN INC
3645,-247037000.0,LiabilitiesNoncurrent,2,921299_FIBROGEN INC
3796,-247037000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,921299_FIBROGEN INC
3379,-76885000.0,OperatingLeaseLiabilityNoncurrent,3,921299_FIBROGEN INC
3154,-254746000.0,LiabilitiesCurrent,2,921299_FIBROGEN INC
2347,-71282000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,921299_FIBROGEN INC
2398,-71282000.0,AccountsPayableCurrent,2,921299_FIBROGEN INC
2089,538544000.0,Assets,1,921299_FIBROGEN INC
2091,107995000.0,AssetsNoncurrent,2,921299_FIBROGEN INC
2041,4672000.0,OtherAssetsNoncurrent,2,921299_FIBROGEN INC
1368,18693000.0,PropertyPlantAndEquipmentNet,4,921299_FIBROGEN INC
1634,76674000.0,OperatingLeaseRightOfUseAsset,2,921299_FIBROGEN INC
868,430549000.0,AssetsCurrent,2,921299_FIBROGEN INC
260,42456000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,921299_FIBROGEN INC
455,42456000.0,InventoryNet,2,921299_FIBROGEN INC
320,17654000.0,ReceivablesNetCurrent,3,921299_FIBROGEN INC
232,-3491000.0,GrossProfit,1,921299_FIBROGEN INC
601,34275000.0,SellingGeneralAndAdministrativeExpense,3,921299_FIBROGEN INC
1557,5884000.0,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures,6,921299_FIBROGEN INC
1002,-1000.0,GainLossOnDispositionOfAssets1,1,921299_FIBROGEN INC
144,3491000.0,CostOfRevenue,1,921299_FIBROGEN INC
3809,-4570000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,921299_FIBROGEN INC
3494,-7063000.0,OtherLiabilitiesNoncurrent,2,921299_FIBROGEN INC
1848,5884000.0,LongTermInvestmentsAndReceivablesNet,3,921299_FIBROGEN INC
1626,5884000.0,LongTermInvestments,1,921299_FIBROGEN INC
1494,5884000.0,EquityMethodInvestments,1,921299_FIBROGEN INC
281,167399000.0,ShortTermInvestments,1,921299_FIBROGEN INC
2903,-76705000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,921299_FIBROGEN INC
2590,-76705000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,921299_FIBROGEN INC
1912,-76705000.0,NetIncomeLoss,1,921299_FIBROGEN INC
1077,-76705000.0,ProfitLoss,2,921299_FIBROGEN INC
1820,-78297000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,921299_FIBROGEN INC
2399,74000.0,IncomeTaxExpenseBenefit,1,921299_FIBROGEN INC
2257,-78223000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,921299_FIBROGEN INC
2149,-77427000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,921299_FIBROGEN INC
1854,2372000.0,InterestAndDebtExpense,2,921299_FIBROGEN INC
1709,2372000.0,InterestExpense,1,921299_FIBROGEN INC
2130,-1036000.0,NonoperatingIncomeExpense,1,921299_FIBROGEN INC
1264,-76091000.0,OperatingIncomeLoss,1,921299_FIBROGEN INC
1112,109185000.0,OperatingExpenses,1,921299_FIBROGEN INC
491,74486000.0,ResearchAndDevelopmentExpense,2,921299_FIBROGEN INC
961,-1000.0,GainLossOnSaleOfPropertyPlantEquipment,1,921299_FIBROGEN INC
456,423000.0,DepreciationAndAmortization,4,921299_FIBROGEN INC
1478,-796000.0,IncomeLossFromEquityMethodInvestments,1,921299_FIBROGEN INC
565,423000.0,FinanceLeaseRightOfUseAssetAmortization,3,921299_FIBROGEN INC
1864,2072000.0,RestrictedCashAndInvestmentsNoncurrent,3,921299_FIBROGEN INC
2306,2072000.0,RestrictedCashAndCashEquivalentsNoncurrent,3,921299_FIBROGEN INC
2764,-16495000.0,ContractWithCustomerLiabilityCurrent,3,921299_FIBROGEN INC
3279,-163089000.0,DeferredRevenueNoncurrent,2,921299_FIBROGEN INC
3339,-163089000.0,ContractWithCustomerLiabilityNoncurrent,3,921299_FIBROGEN INC
990,-1000.0,GainLossOnDispositionOfAssets,4,921299_FIBROGEN INC
845,423000.0,AmortizationOfDeferredCharges,1,921299_FIBROGEN INC
2710,-16495000.0,DeferredRevenueCurrent,2,921299_FIBROGEN INC
3853,-19967000.0,MinorityInterest,1,921299_FIBROGEN INC
2603,-36161000.0,NoninterestIncome,1,921299_FIBROGEN INC
110,-36161000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,921299_FIBROGEN INC
581,74909000.0,OperatingCostsAndExpenses,2,921299_FIBROGEN INC
577,355949000.0,CashCashEquivalentsAndShortTermInvestments,4,921299_FIBROGEN INC
229,17654000.0,AccountsReceivableNetCurrent,3,921299_FIBROGEN INC
207,17654000.0,AccountsNotesAndLoansReceivableNetCurrent,4,921299_FIBROGEN INC
645,188550000.0,CashAndCashEquivalentsAtCarryingValue,3,921299_FIBROGEN INC
